- Udyam number
- UDYAM-MH-19-0005874

About Thaiger Pharma Private Limited
Data last updated:
Thaiger Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2014PTC253312. Its GSTIN is 27AAECT9414C1ZF (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹51.25 Lakh. It is led by directors Aftab Akhtar Attarwala and Irfan Gulam Ahmed Dhorajiwala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.77 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹11.2 Lakh (net margin 0.9%) and EBITDA of ₹30.38 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 9% over five years.
Thaiger Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-19-0005874). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website thaiger-pharmaceuticals.com.
Company details
Recognitions & Rankings of Thaiger Pharma
Contact details
Thaiger Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is thaiger-pharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGala No. 14 – D Floor – Ground Plot – 14C, Allana Compound Dr. Anandrao Nair Road Agripada Jacob Circle, Mumbai, Maharashtra, India – 400011
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Thaiger Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Thaiger Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Thaiger Pharma Private Limited, buy the company report.
Financials of Thaiger Pharma Private Limited
FY 2025 filings availableThaiger Pharma Private Limited reported revenue of ₹12.77 Cr (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 15% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Thaiger Pharma Private Limited, buy the company report.
Board of directors of Thaiger Pharma Private Limited
Thaiger Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aftab Akhtar Attarwala | Director | 27 Mar 2023 | 3 Years 7 Months | Current |
| Irfan Gulam Ahmed Dhorajiwala Also directs: Thaiger Built IT Better LLP, Thaiger LLP, Thaiger Nutraceuticals Private Limited and 1 more | Director | 17 Feb 2014 | 12 Years 9 Months | Current |
Peer comparison
Thaiger Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Apco Pharma Limited | ₹12.8 Cr (FY 2024) | 14.0% | New Delhi, Delhi, India | |||
| Salubrity Biotech Limited | ₹12.8 Cr (FY 2025) | 2.0% | Kolkata, West Bengal, India | |||
| Habitare Pharma Private Limited | ₹12.79 Cr (FY 2025) | 17.0% | Barwala, Haryana, India | |||
| Thaiger Pharma Private Limitedthis company | ₹12.77 Cr (FY 2025) | ₹11.2 Lakh | 0.9% | -15.0% | Mumbai, Maharashtra, India | |
| Soft Touch Pharmaceutical India Limited | ₹12.75 Cr (FY 2025) | 14.0% | Solan, Himachal Pradesh, India | |||
| Shalman Pharmaceuticals Private Limited | ₹12.73 Cr (FY 2024) | -3.0% | Vadodara, Gujarat, India | |||
| Reallab Biotech Private Limited | ₹12.68 Cr (FY 2025) | 23.0% | Meerut, Uttar Pradesh, India | |||
| Sankur Pharmaceuticals Private Limited | ₹12.67 Cr (FY 2024) | 22.0% | Agra, Uttar Pradesh, India |
To see the full peer comparison of Thaiger Pharma Private Limited, buy the company report.
Auditor
Thaiger Pharma Private Limited is audited by A.H. Bohra & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.H. Bohra & Co. | FY 2024 | 101545W |
Shareholding
The shareholding of Thaiger Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Thaiger Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Thaiger Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Thaiger Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Thaiger Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECT9414C1ZF | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Thaiger Pharma Private Limited, buy the company report.
Recent activity
Thaiger Pharma Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Aftab Akhtar Attarwala was appointed as Director on 27 Mar 2023.
Frequently asked questions
Thaiger Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 February 2014 (12+ years old) and is registered under CIN U24100MH2014PTC253312.
Thaiger Pharma has 2 current directors:
- Aftab Akhtar Attarwala - Director
- Irfan Gulam Ahmed Dhorajiwala - Director
The latest financial statements of Thaiger Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Thaiger Pharma is 27AAECT9414C1ZF, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Thaiger Pharma is U24100MH2014PTC253312. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Thaiger Pharma was incorporated on 17 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Thaiger Pharma by revenue are Apco Pharma Limited, Salubrity Biotech Limited, Habitare Pharma Private Limited, Soft Touch Pharmaceutical India Limited, Shalman Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Aftab Akhtar Attarwala was appointed as Director on 27 Mar 2023. Reshma Irfan Ahmed ceased to be Director on 27 Mar 2023. Irfan Gulam Ahmed Dhorajiwala was appointed as Director on 17 Feb 2014.
Yes, Thaiger Pharma is registered as an MSME under Udyam registration (number: UDYAM-MH-19-0005874).
Thaiger Pharma can be reached through the website thaiger-pharmaceuticals.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Thaiger Pharma is at Gala No. 14 – D Floor – Ground Plot – 14C, Allana Compound Dr. Anandrao Nair Road Agripada Jacob Circle, Mumbai, Maharashtra, India – 400011.

